Washington Magazine

Rising Recognition of Depression as a Medical Disorders, the Global Anti-depressant Drugs, Devices, and Therapies Market Is Evaluated to Grow at 2.12% of CAGR by 2025

Rising Recognition of Depression as a Medical Disorders, the Global Anti-depressant Drugs, Devices, and Therapies Market Is Evaluated to Grow at 2.12% of CAGR by 2025

The global anti-depressant drugs, devices, and therapies market were valued at $16442 million in 2016 and are anticipated to reach $19712 million by 2025, growing at an estimated CAGR of 2.12%.
According to the new market research report launched by Inkwood Research, The global anti-depressant drugs, devices, and therapies market was valued at $16442 million in 2016 and is anticipated to reach $19712 million by 2025, growing at an estimated CAGR of 2.12%, during the forecast period 2017-2025.

Browse 30 market data Tables and 41 Figures spread through 167 Pages and in-depth analysis on the “Global Anti-depressant drugs, devices, and therapies market  by Components (serotonin and norepinephrine reuptake inhibitors(MAOIS) and other medications) by mental health devices (global deep brain simulator market, fisher wallace stimulator, transcranial magnetic simulator (TMS) and other devices) by therapies (cognitive behaviour therapy (CBT), electroconvulsive therapy (ECT), rational emotive behavior therapy (REBT) and other therapies) & by Geography- Regional Trends & Forecast to 2025”

Read Complete Report with TOC @ https://www.inkwoodresearch.com/reports/global-anti-depressant-drugs-devices-and-therapies-market-forecast-2017-2025

 

This insightful market research report from Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, and Rest of World the report is a valuable asset for the existing players, new entrants, and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain.

 

Anti-depressant drugs, devices, and therapies market scenario

Rising demand of generic drug over branded drugs due to high cost, increasing consciousness of depression as a medical disorder and surging sales of antidepressants are the vital reasons for the growth of global anti-depressant, drugs, devices, and therapies market.

The Anti-Depressant drugs, devices, and therapies market report provide data tables, includes charts and graphs for visual analysis.

 

 Market Segmentation

On the basis of the component, the Global Anti-depressant drugs, devices, and therapies market is segmented as follows:

  • Serotonin and norepinephrine reuptake inhibitors (SNRIs)
  • Norepinephrine and dopamine reuptake inhibitors (NDRI)
  • Atypical Antidepressants
  • Monoamine oxidase inhibitors (MAOIs)

 

On the basis of mental health devices, the Global Anti-depressant drugs, devices, and therapies market is segmented as follows:

  • Global deep brain simulator market
  • Fisher Wallace stimulator
  • Transcranial magnetic simulator (TMS)
  • Other devices

 

On the basis of  market therapies, the Global Antidepressant drugs, devices, and therapies market is segmented as follows:

  • Cognitive behavior therapy (CBT)
  • Electroconvulsive Therapy (ECT)
  • Rational emotive behavior therapy (REBT)
  • Other therapies

 

Get Sample Copy of Report @ https://www.inkwoodresearch.com/reports/global-anti-depressant-drugs-devices-and-therapies-market-forecast-2017-2025/#request-free-sample

 

Report Highlights

– The report provides a detailed analysis of current and future market trends to identify the investment opportunities
– Market forecasts till 2025, using estimated market values as the base numbers
– Key market trends across the business segments, regions and countries
– Key developments and strategies observed in the market
– Market dynamics such as drivers, restraints, opportunities and other trends
– In-depth company profiles of key players and upcoming prominent players
– Growth prospects among the emerging nations through 2025
– Market opportunities and recommendations for new investments

 

Companies Profiled

–          Abbot Laboratories

–          Allergan PLC

–          Boehringer Ingelheim GMBH

–          Brainsway

–          Cyberonics Inc.

–          ELI Lilly and Company

–          Hoffmann-LA Roche LTD

–          Glaxosmithkline

–          Lundbeck AS

–          Mayo Clinic

–          Neuronetics

–          Pfizer

–          Sanofi

–          Sun Pharmaceuticals

–          Teva Pharmaceuticals Industries

 

Related Reports:

GLOBAL CENTRAL NERVOUS SYSTEM MARKET FORECAST 2017-2025

GLOBAL CANNABIS TESTING MARKET FORECAST 2017-2025

GLOBAL OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025 

Media Contact
Company Name: Inkwood Research
Contact Person: Clive Cooper
Email: Send Email
Phone: 1 857-302-4704
Address:169, Harrison Avenue
City: Boston
State: Massachusetts
Country: United States
Website: https://www.inkwoodresearch.com/